Skip to search.
 TSX Down 0.94% TSX Ventures Down 3.46%

Amgen Inc. (AMGN)

-NasdaqGS
170.84 Down 3.56(2.04%) Aug 24, 4:00PM EDT
|After Hours : 170.88 Up 0.04 (0.02%) Aug 24, 7:48PM EDT
Prev Close:174.40
Open:174.00
Bid:170.27 x 300
Ask:171.00 x 500
1y Target Est:191.06
Beta:1.28822
Earnings Date:Oct 26 - Oct 31 (Est.)
Day's Range:170.28 - 174.87
52wk Range:130.09 - 176.64
Volume:3,054,987
Avg Vol (3m):2,872,680
Market Cap:127.85B
P/E (ttm):17.48
EPS (ttm):9.77
Div & Yield:4.00 (2.30%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
AMGNDown 2.04%127.85B
JNJDown 0.61%324.78B

Key Statistics

Forward P/E (1 yr):13.68
P/S (ttm):5.81
Ex-Dividend Date:15-Aug-16

Analysts

Annual EPS Est (Dec-16) :11.37
Quarterly EPS Est (Sep-16) :2.80
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):1.80

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amgen Inc., a biotechnology company, engages in discovering, developing, manufacturing, and delivering human therapeutics worldwide. It offers products for the treatment of illness in the areas of oncology/hematology, cardiovascular, inflammation,... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback